Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
Top Cited Papers
- 1 April 2016
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 17 (4), 425-439
- https://doi.org/10.1016/s1470-2045(15)00613-0
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- AstraZeneca
- Pfizer
- AstraZeneca
- Chugai
- Eli Lilly
- GSK
- Daiichi-Sankyo
- Pfizer
- Novartis
- Pfizer
- US Department of Defense Breast Cancer Innovator Award
- Revlon/University of California, Los Angeles Women's Cancer Research Program
- Peter and Denise Wittich Breast Cancer Program
This publication has 32 references indexed in Scilit:
- Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral BloodClinical Cancer Research, 2012
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast CancerThe New England Journal of Medicine, 2012
- ERα-Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast CancerCancer Discovery, 2011
- Adaptive Changes Result in Activation of Alternate Signaling Pathways and Acquisition of Resistance to Aromatase InhibitorsClinical Cancer Research, 2011
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised studyThe Lancet, 2011
- Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancerBreast Cancer Research, 2011
- Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancerAnnals of Oncology, 2011
- PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroBreast Cancer Research, 2009
- International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent ChemotherapyJNCI Journal of the National Cancer Institute, 2009
- A small sample study of the STEPP approach to assessing treatment–covariate interactions in survival dataStatistics in Medicine, 2009